Material Testing Reactors (MTRs) are necessary for development and qualification of materials and nuclear fuel used in nuclear industry. The related studies contribute to safety and optimization of existing or upcoming nuclear power reactors and to development of future reactors.
Most of the irradiation tools utilized by industry are now ageing in the western world. Sustainability of a high performance experimental capacity and related expertise for the coming decades is mandatory. There is a consensus on the necessity to design and build a new Material Testing Reactor (MTR) to support operation of existing power reactors fleets and qualification of future technologies systems.
JHR will be used for nuclear medicine. It will supply hospitals with short-lived radioisotopes used for medical imaging or therapeutic purposes. This research facility may be promoted through non-nuclear industrial application capabilities. JHR will provide high performance silicon used in electronic power devices, such as those included in electrical and hybrid vehicles or in energy control systems.
|The present production of radioelement at CEA|
|Moly 99 : reactors 2011|
Coping with this context, the Jules Horowitz Reactor (JHR), built on the Cadarache site, will be a major infrastructure of European interest in the fission domain, open to the international collaboration.
The Jules Horowitz Reactor will be built and operated in the framework of an international cooperation between several organizations bound by a Consortium Agreement.
The 11th bilateral agreement has been signed on 12th March 2013 with the United Kingdom. Up to now, the present partners are as follows:
|Consortium agreement signature on march 19th, 2007||François Fillon, France Prime minister on visit, the 3th of may 2010|
Revision : 2013-09
©CEA All rights reserved